Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$11.95 +0.12 (+1.01%)
As of 02:09 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$11.15
$11.95
50-Day Range
$9.71
$20.98
52-Week Range
$8.89
$24.50
Volume
260,366 shs
Average Volume
470,676 shs
Market Capitalization
$518.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.83
Consensus Rating
Moderate Buy

Company Overview

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

BBNX Stock News Headlines

Beta Bionics, Inc. (BBNX)
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Beta Bionics: Slowing Down Or Being Conservative?
Beta Bionics to Host Investor Event on June 22, 2025
Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus
BBNX Beta Bionics, Inc.
Beta Bionics welcomes new board member Gerard Michel
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 at the beginning of the year. Since then, BBNX stock has decreased by 52.1% and is now trading at $11.40.
View the best growth stocks for 2025 here
.

Beta Bionics, Inc. (NASDAQ:BBNX) released its quarterly earnings data on Tuesday, March, 25th. The company reported ($1.82) earnings per share for the quarter, missing the consensus estimate of ($0.42) by $1.40. The business had revenue of $20.44 million for the quarter, compared to analyst estimates of $20.01 million.
Read the conference call transcript
.

Beta Bionics (BBNX) raised $204 million in an initial public offering (IPO) on Thursday, January 30th 2025. The company issued 12,000,000 shares at $17.00 per share.

Beta Bionics' lock-up period expires on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. After the expiration of Beta Bionics' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Top institutional shareholders of Beta Bionics include Jennison Associates LLC (0.16%), Evanson Asset Management LLC (0.09%), Values First Advisors Inc. (0.09%) and Bank of New York Mellon Corp (0.06%). Insiders that own company stock include Hadley Harbor Aggre Wellington and Mike Mensinger.
View institutional ownership trends
.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/25/2025
Today
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.83
High Stock Price Target
$30.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+109.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$65.12 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$512.82 million
Optionable
N/A
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners